<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

3 min read

SNIS 2023: New Frontiers in Stroke Care: An Interview with J Mocco, MD

By Anne Staylor on 9/19/23 9:45 AM

SNIS President J Mocco, MD, discusses emerging technologies and new frontiers in neurointervention in an interview with SmartTRAK.

J Mocco, MD, President of the Society of Neurointerventional Surgery (SNIS), discusses the latest research and innovation in stroke care in an interview with SmartTRAK at the 20thAnnual Meeting of the SNIS recently held in San Diego, CA. To find out more regarding important research, emerging technologies and new frontiers in stroke care, listen to the following video. (27:12 min). A complete transcript of the interview can be downloaded below.

SmartTRAK: Hi, this is Anne Staylor with SmartTRAK. Today I'm covering the Society of Neurointerventional Surgery annual meeting here in San Diego, and I have the pleasure of speaking to J Mocco, MD, president of the SNIS. Dr. Mocco, thank you for talking with me today.

J Mocco, MD: Thank you very much for having me.

Well, this year I felt a lot of energy and vibrancy at the meeting, particularly when I walked into the exhibit hall, which is nice after some of the years we've had with COVID. One of the things I wanted to ask you is what are some of the exciting research studies at SNIS this year? Maybe you could just highlight some of the key research that is presented here at the meeting.

Absolutely. I have to say this year was truly spectacular. The depth and breadth of new and exciting research and reports on technology and studies. This year we saw presentations on completely new technologies to treat brain aneurysms, multiple leap forwards in technologies to better remove clots from brains and cure people with stroke. Had very robust discussions on systems of care and how best to evaluate stroke patients. Is the current standard adequate? Should we have different methods of evaluating patient success? They're just examples of the really amazing things that are happening in this space in general, and particularly ...

To download the complete transcript of the interview with J Mocco, MD, President of SNIS, conducted by Anne Staylor, SmartTRAK Executive Editor, VP & GM of Neuro Therapies, just click the button below.Download the Transcript

Continue Reading
1 min read

Biologics in Sports Medicine - Key Takeaways from the 2023 AOSSM Meeting (Part 2)

By Kim French on 9/12/23 9:30 AM

SmartTRAK highlights key takeaways from the 2023 AOSSM Meeting

As the number of patients seeking treatment for musculoskeletal conditions increases, the orthobiologic market continues to grow, resulting in physicians and companies offering more innovative treatment options. At the 2023 American Orthopaedic Society for Sports Medicine (AOSSM) Annual Meeting in Washington, biological healing was a hot topic. In this article, SmartTRAKidentifies the latest market developments and innovations that will drive growth in the market for sports medicine-related orthobiologics.

This article is Part Two in a two-part series highlighting the key takeaways from this meeting. To download and read Part One, click Biologics in Musculoskeletal Medicine.

To download Part Two of the series "Biologics in Musculoskeletal Medicine," by Kimberly French, SmartTRAK's GM, Orthobiologics and Regenerative Medicine, just click the button below.Download the Article

Continue Reading
2 min read

Modeling the Cost-Effectiveness of Pressure Injury Prevention

By Anikó Szekér on 9/5/23 9:45 AM

Csaba Dózsa, habil PhD MSc, Health Economist, discusses his model for cost-effectiveness in the prevention and treatment of pressure injuries in an interview with SmartTRAK.

In this interview, Prof. Dózsa unveils his groundbreaking pressure injury (PI) prevention costing model. With a 20-year background in health economics, he embarked on this journey from Hungary's National Health Insurance Fund. His expertise shaped the German DRG point system locally and steered home care development. Establishing Med-Econ Ltd., he delved into diverse health economic studies, culminating in a sophisticated, non-linear model for PI prevention costs.

The model's complexity stems from recognizing intricate healthcare inputs and outcomes. It calculates annual PI costs across scenarios: implementing preventive care bundles with or without multi-layer dressings, and treatment-only approaches. Designed as a calculation framework, it showcases the efficacy of preventive wound care.

Among the many questions answered by Prof, Dózsa in this interview are:

  • Can this model be used in any health and political environment?
  • How does the use of this model affect a hospital's use of dressings?
  • How would you describe the cost structure of prevention and treatment?
  • Can this model and its outcome lead to systemic changes?
  • How long would it take a hospital or hospital system to adapt the model to their data?
  • Can this model be used equally in the case of higher-risk patients, older patients or in hospitals that see proportionally more of these patients?

The interview, conducted by Anikó Szekér, SmartTRAK Senior Analyst, Wound Care, offers insights into Prof. Dózsa's journey and his PI prevention costing model's potential. To download a complete transcript of the interview, just click the button below.Download the Transcript

Topics: Wound Care
Continue Reading
2 min read

ASPN 2023: Advancements in Interventional Pain Treatment

By Shelly Caruso on 8/28/23 9:30 AM

SmartTRAK was on-site at ASPN 2023 covering industry-sponsored RCT updates and data reveals, as well as new players and trends in the interventional pain space.

As the number of patients suffering from chronic pain increases, the interventional pain market continues to grow. Physicians and device developers are rising to the challenge by offering more personalized pain treatment options for an expanding list of indications. As a result, new differentiators for spinal cord stimulation (SCS) players have emerged, as well as newcomers in the peripheral nerve stimulation (PNS) market. Beyond neuromodulation, minimally-invasive surgical (MIS) spine procedures, sacroiliac (SI) joint fusion and regenerative medicine products also provide innovative solutions for chronic pain management. In this interesting article, SmartTRAK highlights the newest data, innovation and market developments at the American Society of Pain and Neuroscience (ASPN) 2023 Annual Meeting held in Miami, FL.

Among the many topics discussed in comprehensive detail in this article, which can be downloaded here, are:

  • SCS Sees Cutthroat Competition
    • MRI Compatibility and Closed-Loop SCS
    • Painful Diabetic Neuropathy (PDN)
    • Artificial Intelligence, Programming Solutions and Remote Monitoring
  • Expanding Horizons in PNS
    • Types of Peripheral Nerve Stimulation
    • Outcomes, Comfort and Wearability for Externally-powered Devices
    • Injectrode Technology
  • What’s New in MIS Spine and SI Joint Fusion
    • Leveraging Enabling Technology for Pain Procedures
    • Innovations in MIS Spine and SI Joint Instrumentation
  • Scientific Focus on Biologics and Regenerative Medicine

To identify current and future trends in interventional pain management and PNS, SmartTRAK recently surveyed 30 interventional pain physicians, including 18 who perform PNS, to get an inside view of procedure trends, what treatments and devices they use and who they see as future winners in the chronic pain space. To purchase the results of this comprehensive survey, see SmartTRAK’s Trends in Interventional Pain Management and PNS.

To download a complimentary copy of the complete "ASPN 2023: Advancements in Interventional Pain Treatment" article, just click the button below. Download the ASPN 2023 Article

Continue Reading
2 min read

Biologics in Musculoskeletal Medicine

By Kim French on 8/18/23 9:30 AM

SmartTRAK highlights key takeaways from the 2023 Biologic Association Meeting

At the 2023 Annual Meeting in monumental Washington DC, the Biologic Association and the American Society of Orthopaedic Surgeons (AAOS) teamed up with American Orthopaedic Society for Sports Medicine (AOSSM) to spotlight the growing interest in and latest advancements of biologics in musculoskeletal medicine. Taking center stage and garnering attention was the idea of “biological healing” and the use of biologics in various conditions and at different points of a continuum of care.

Not surprisingly, the Biological Association focused more on autologous therapies, cell culturing and the next generation of biologics, while the AOSSM meeting explored the current use and growing trends of traditional orthobiologics in orthopedic applications. This article, which is downloadable here, is part one in a two-part series highlighting key takeaways from the Biologic Association meeting, including:

  • Biologic Association Key Takeaways
  • Rules of Engagement: Regulations and Needed Standards
    • “Same Surgical Procedure Exception” Guidance
    •  Standards for Autologous Orthobiologics
    • Driving Better Patient Outcomes
  • Current Use of Autologous Therapies and Next Generation of Biologics
    • Current Practice
    • Next Generation of Biologics
  • Notable Investigative Technologies

Although several biologics seem promising to treat musculoskeletal conditions, there is still an uphill battle for widespread use. Current challenges include ...

To download "Biologics in Musculoskeletal Medicine," Part One of the series of articles by Kimberly French, SmartTRAK's GM, Orthobiologics and Regenerative Medicine, just click the button below. Look for Part Two in this series, which will cover key takeaways from AOSSM, highlighting the current use of Orthobiologics and growing trends, in the coming weeks.Download the Article

Continue Reading
3 min read

Statera Medical: Smart Shoulder Implant - An Interview with Samuel Bourdon

By Nick Fitzpatrick on 8/11/23 11:46 AM

Samuel Bourdon, Co-Founder and Chief Executive Officer of Statera Medical discusses Statera Medical’s development of a smart shoulder implant.

In an interview withSmartTRAK,Samuel Bourdon, the Co-Founder and Chief Executive Officer of Statera Medical, discusses how Statera Medical came to be, why their focused on creating a smart implant for the shoulder arthroplasty market and where he sees the Company going in the future.

To find out more, including the design rationale behind Statera’s smart shoulder ecosystem and how Statera fits in the shoulder arthroplasty market, click on the following video to listen to the full interview (29:25). If you would like to download the complete transcript of the interview, click here.

SmartTRAK: Hey guys, this is Nick with SmartTRAK. I'm here with Samuel Bourdon, CEO and founder of Statera Medical. I appreciate you joining me this morning and doing this interview. Samuel, can you give us an introduction about your yourself and a brief background of your experience in the orthopedics industry?

Samuel Bourdon: I'm a mechanical engineer by training. I have worked in product development since 2012 and mostly in the aerospace and recreational product. And when I turned 30, I quit my job and decided to go back to school to do a full-time master degree in biomedical engineering. And then I managed to do a master in business administration part-time during the same period. So before Statera Medical I had no experience in orthopedic industry at all, so it's a first time for me.

That's definitely monumental. Why'd you switch from aerospace to biomedical?

SB: Yeah, I just hit a bigger why in my career and I wanted to put a human at the center of it, so that's what made me took that decision.

Where did you get your master's in biomed from?

SB: From Polytechnique Montreal. It's the same university I got my mechanical engineer degree.

Let's dive into the company that you founded, Statera Medical. So what was the inspiration behind founding Statera Medical, and what's your mission statement behind it?

SB: What happened is I met another engineer and an orthopedic surgeon, and it was really all about reducing complication rates and improving patient outcomes, which ultimately results in ...

To download the complete transcript of SmartTRAK's interview with Samuel Bourdon, the Co-Founder and CEO of Statera Medical, just click the button below. Download the Transcript

Continue Reading
2 min read

ArthroFree: The Surgical Camera for the Wireless Era

By Andy Knapik on 8/2/23 3:39 PM

In a joint interview with Eugene Malinskiy, founder and CEO of Lazurite, and orthopedic surgeon Dr James Voos, we discuss the world’s first wireless surgical camera, the Lazurite ArthroFree camera.

Eugene Malinskiy, the founder and CEO of Lazurite, and orthopedic surgeon Dr. James Voos discuss the technological and clinical benefits of the new ArthroFree camera, the world’s first fully wireless surgical camera, with Andy Knapik, SmartTRAK's Senior Analyst, Soft Tissue & Arthroscopic Technologies.

To learn more about Lazurite and the ArthroFree System, click the following video to watch the interview (27:05 min).  For more details, interview topics by timecode are provided below. To download a complete transcript of the interview, click here.


Interview Topics By Timecode

1:25 Background of Lazurite and the ArthroFree camera.

7:05 Surgeon impressions of the ArthroFree camera.

10:10 Camera integration, image quality, battery life, ergonomics.

16:05 How the camera connects to the monitor and image capture.

19:22 How do facilities react to purchasing the ArthroFree.

22:05 Uses of the ArthroFree camera.

To download the complete transcript of the interview with Eugene Malinskiy, the founder and CEO of Lazurite, and orthopedic surgeon Dr. James Voos, just click the button below. Download the Transcript

Continue Reading
9 min read

What's New in the Neurovascular Market

By Anne Staylor on 8/1/23 9:53 AM

SmartTRAK constantly monitors the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, trends, new products, patents, financial data and competitor developments in the global Life Sciences industry. Contact Us if you'd like to learn how to receive these expert insights daily. Our users think it's the perfect way to start their day.

The following is just a small sampling of recent Neurovascular market updates from around the world compiled, reviewed and posted daily by our SmartTRAK analysts.

New Products:

  • ZOOM* - Imperative Care* 

    Imperative Care announced the completion of first cases using the recently FDA-cleared Zoom 88 Support catheter. One of the cases was an AIS patient with a tandem occlusion treated at Erlanger Health System in Chattanooga, TN. SmartTRAK reported FDA clearance of the device on Jun 15.

  •  MicroPort NeuroTech announced in May 2023 that it has completed the first clinical implantation of its NUMEN Detachable Embolization Coil for neurovascular aneurysm treatment in both the UK and Ireland.

  • EOSolutions Launches Dr. Banner BGC

     EOSolutions announced the full commercial launch of its Dr. Banner, Balloon Guide Catheter (BGC), developed in collaboration with InNeuroCo. According to the Company, the BGC features a 0.091 ID, proximal stability, distal trackability and a compliant polyurethane balloon.


  • phenox*

    phenox GmbH’s US Patent Application “Insertion System For Implants For Treatment Of Bifurcation Aneurysms” was published disclosing a Y-shaped tubular implant and Y-shaped insertion catheter for bifurcation aneurysm treatment. 20230233347

  • Aspiration Catheter with an Adjustable Tip

    The Univ of Toledo’s US Patent Application “Aspiration Catheter With An Adjustable Tip For The Intracranial Circulation” was published disclosing a neurovascular aspiration catheter with an adjustable tip controlled by pull wires. 20230233221

    Learn More about Subscribing to SmartTRAK

Topics: Neurovascular
Continue Reading
2 min read

Fingers Crossed for a Market Recovery: Q123 Neuromodulation Market Recap

By Anne Staylor on 7/28/23 9:23 AM

Neuromodulation companies are keeping their fingers crossed that the positive growth in Q123 is a sign that market recovery is well underway.  

With three of the four top neuromodulation companies reporting high-single-digit (HSD) growth in Q123, manufacturers are keeping their fingers crossed that market recovery is well underway. The impact of COVID has lessened significantly and several manufacturers reported that near-term improvement in healthcare staffing levels and post-COVID demand helped drive strong underlying procedure volumes in Q123. Competitors are also seeing gains on new and differentiated product offerings and expanded indications.

Continue Reading
2 min read

CMS Proposed Rule Incentivizes Home Use of Disposable NPWT

By Terry Hayslett on 7/25/23 9:30 AM

The Centers for Medicare and Medicaid Services (CMS) projects Medicare home health spending in the US will grow at an 8-year (2023-2031) CAGR of +8.6% compared to +7.4% for hospital expenditures. These projections help validate that healthcare services are shifting to the home care setting. The migration is driven by efforts to reduce costs, improve access and enhance the quality of care. Policymakers continue to manipulate reimbursement formulas to incentivize change. CMS recently released the CY 2024 Home Health Prospective Payment System (PPS) Proposed Rule that includes reimbursement policy revisions that could potentially increase the utilization of disposable negative pressure wound therapy (dNPWT) in the home health setting. This free downloadable article highlights:

  • The Trajectory of dNPWT,
  • Historical Challenges Associated with the Uptake in the Home Setting
  • Incremental Policy Efforts Designed to Mitigate Those Challenges
  • Billing Complexity Stalling Growth
  • Incremental Changes Show Progress
  • Impact of Proposed Policy Changes. 

With the establishment of a separate payment for the dNPWT and the relatively simpler billing processes, the proposed CMS changes are a net positive for manufacturers treating wounds in the home health setting. However, given the growing competition ...

To download the complete "CMS Proposed Rule Incentivizes Home Use of Disposable NPWT" perspective article by Terry Hayslett, SmartTRAK Senior Analyst, Advanced Wound Care, just click the button below. Download the Article

Topics: Wound Care
Continue Reading
  • There are no suggestions because the search field is empty.

Follow Us on Social Media

Recent Articles